Literature DB >> 9988161

Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival.

R F Sadek1, A S Khan, G Stevens, C J Peters, T G Ksiazek.   

Abstract

In May 1995, an international team characterized and contained an outbreak of Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo. This study reports the descriptive features of this outbreak along with a statistical analysis of the outbreak data. Proportional hazards analysis was used to examine the effect of age, phase of the outbreak, and sex on the risk of death, and a conditional probability analysis was used to examine the effectiveness of whole blood transfusion from convalescent patients on survival. Two hundred fifty case-patients (80.7%) died. The main predictor of survival in the proportional hazards model was age. No statistical evidence of a survival benefit of transfusion of blood from convalescent patients was evident after adjusting for age, sex, and the days since onset of symptoms (P = .1713).

Entities:  

Mesh:

Year:  1999        PMID: 9988161     DOI: 10.1086/514311

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Authors:  T Maruyama; L L Rodriguez; P B Jahrling; A Sanchez; A S Khan; S T Nichol; C J Peters; P W Parren; D R Burton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.

Authors:  Paul W H I Parren; Tom W Geisbert; Toshiaki Maruyama; Peter B Jahrling; Dennis R Burton
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 3.  Ebola Virus Disease: Focus on Children.

Authors:  Athena P Kourtis; Kristie Appelgren; Michelle S Chevalier; Anita McElroy
Journal:  Pediatr Infect Dis J       Date:  2015-08       Impact factor: 2.129

Review 4.  Ebola virus disease.

Authors:  Nicholas J Beeching; Manuel Fenech; Catherine F Houlihan
Journal:  BMJ       Date:  2014-12-10

Review 5.  What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection.

Authors:  Hana Golding; Surender Khurana; Marina Zaitseva
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

6.  Early immune responses accompanying human asymptomatic Ebola infections.

Authors:  E M Leroy; S Baize; P Debre; J Lansoud-Soukate; E Mavoungou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

7.  Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

Authors:  M Gupta; S Mahanty; M Bray; R Ahmed; P E Rollin
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations.

Authors:  E Mupere; O F Kaducu; Z Yoti
Journal:  Afr Health Sci       Date:  2001-12       Impact factor: 0.927

9.  Therapeutics for postexposure treatment of Ebola virus infection.

Authors:  Marina Jerebtsova; Sergei Nekhai
Journal:  Future Virol       Date:  2015-03       Impact factor: 1.831

Review 10.  Emerging and zoonotic infections in women.

Authors:  Regan N Theiler; Sonja A Rasmussen; Tracee A Treadwell; Denise J Jamieson
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.